Product Details for: KEBILIDI
RETURN TO SEARCH RESULTS
PRODUCT LABEL
Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Suspension
Intraputaminal
5.6x10^11VG/ML
Single-Dose Vial
351(a)
KEBILIDI
Rx
Proper Name
eladocagene exuparvovec-tneq
eladocagene exuparvovec-tneq
BLA Number
125722
125722
Applicant
PTC Therapeutics
PTC Therapeutics
Original Approval Date
November 13, 2024
November 13, 2024
Date of First Licensure